Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
14.98
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market closed

DAWN Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Cash & Equivalents
270.39230.7885.26284.3143.7327.33
Short-Term Investments
47.55135.56257.01000
Cash & Cash Equivalents
317.94366.35342.27284.3143.7327.33
Cash Growth
-0.07%7.03%20.39%550.18%59.99%-
Other Current Assets
8.098.935.615.061.340.01
Total Current Assets
326.03375.27347.87289.3745.0727.34
Property, Plant & Equipment
0.440.560.720.280.480
Other Long-Term Assets
0.170.210.470.170.110
Total Long-Term Assets
0.610.771.190.450.590
Total Assets
326.65376.05349.06289.8245.6627.34
Accounts Payable
4.782.580.261.740.20.07
Current Debt
0.30.410.410.20.20
Other Current Liabilities
24.7626.5215.956.711.61.95
Total Current Liabilities
29.8429.5116.628.6622.02
Long-Term Debt
000.410.020.20
Total Long-Term Liabilities
000.410.020.20
Total Liabilities
29.8429.5117.028.672.22.02
Total Debt
0.30.410.810.220.40
Debt Growth
-58.16%-49.82%269.55%-45.27%--
Retained Earnings
-521-458.59-269.67-127.49-56.84-12.78
Comprehensive Income
-0.010.01-0.07000
Shareholders' Equity
296.81346.54332.04281.15-54.21-10.67
Net Cash / Debt
317.64365.94341.46284.0943.3327.33
Net Cash / Debt Growth
0.06%7.17%20.19%555.70%58.52%-
Net Cash Per Share
3.664.595.227.697.844.61
Working Capital
296.2345.77331.26280.7143.0825.32
Book Value Per Share
3.424.345.077.61-9.80-1.80
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).